{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:11:23Z","timestamp":1791198683863,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T00:00:00Z","timestamp":1106611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T00:00:00Z","timestamp":1106611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1038\/sj.tpj.6500301","type":"journal-article","created":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T11:37:54Z","timestamp":1106653074000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)"],"prefix":"10.1038","volume":"5","author":[{"given":"F J","family":"Barrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"de Dios Luna del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hoenicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Garc\u00eda Y\u00e9benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,1,25]]},"reference":[{"key":"BF6500301_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","volume":"14","author":"CM Tanner","year":"1996","unstructured":"Tanner CM, Goldman SM . Epidemiology of Parkinson's disease. Neurol Clin 1996; 14: 317\u2013335.","journal-title":"Neurol Clin"},{"key":"BF6500301_CR2","first-page":"146","volume-title":"Movement Disorders","author":"WRG Gibb","year":"1994","unstructured":"Gibb WRG, Lees AJ . Pathological clues to the cause of Parkinson's disease. In: Marsden CD, Fahn S (eds). Movement Disorders, vol. 3. Butterworth-Heinemann: Oxford, 1994, pp 146\u2013166."},{"key":"BF6500301_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0022-510X(95)00146-S","volume":"133","author":"LG Chia","year":"1995","unstructured":"Chia LG, Cheng LJ, Chuo LJ, Cheng FC, Cu JS . Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease. J Neurol Sci 1995; 133: 73\u201378.","journal-title":"J Neurol Sci"},{"key":"BF6500301_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1176\/ajp.149.4.443","volume":"149","author":"LF Cummings","year":"1992","unstructured":"Cummings LF . Depression and Parkinson's disease: a review. Am J Psychiatric 1992; 149: 443\u2013454.","journal-title":"Am J Psychiatric"},{"key":"BF6500301_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","volume":"53","author":"E Tandberg","year":"1996","unstructured":"Tandberg E, Larsen JP, Arsland D, Cummings JL . The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996; 53: 175\u2013179.","journal-title":"Arch Neurol"},{"key":"BF6500301_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","volume":"54","author":"WM McDonald","year":"2003","unstructured":"McDonald WM, Richard IH, DeLong MR . Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 2003; 54: 363\u2013375.","journal-title":"Biol Psychiatry"},{"key":"BF6500301_CR7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.33588\/rn.3511.2001044","volume":"35","author":"M Serrano-Due\u00f1as","year":"2002","unstructured":"Serrano-Due\u00f1as M . A comparison between low doses of amitriptyline and low doses of fluoxetin used in the control of depression in patients suffering from Parkinson's disease. Rev Neurol 2002; 35: 1010\u20131014.","journal-title":"Rev Neurol"},{"key":"BF6500301_CR8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/jnnp.57.10.1265","volume":"57","author":"VS Kostic","year":"1994","unstructured":"Kostic VS, Filipovic SR, Lecic D, Momcilovic D, Sokic D, Sternic N . Effect of age at onset on frequency of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57: 1265\u20131267.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF6500301_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.31.6.645","volume":"31","author":"R Mayeux","year":"1981","unstructured":"Mayeux R, Stern Y, Rosen J, Leventhal J . Depression intellectual impairment and Parkinson's disease. Neurology 1981; 31: 645\u2013650.","journal-title":"Neurology"},{"key":"BF6500301_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0733-8619(18)31089-2","volume":"2","author":"R Mayeux","year":"1984","unstructured":"Mayeux R . Behavioral manifestations of movement disorders. Neurol Clin 1984; 2: 527\u2013540.","journal-title":"Neurol Clin"},{"key":"BF6500301_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/jnnp.51.6.855","volume":"51","author":"SJ Huber","year":"1998","unstructured":"Huber SJ, Paulson GW, Shuttleworth EC . Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 51: 855\u2013858.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF6500301_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s004150050131","volume":"244","author":"C-Y Liu","year":"1997","unstructured":"Liu C-Y, Wang S-J, Fuh J-L, Liu CH, Yang YY, Liu HC . The correlation of depression with functional activity in Parkinson's disease. J Neurol 1997; 244: 493\u2013498.","journal-title":"J Neurol"},{"key":"BF6500301_CR13","first-page":"176","volume":"7","author":"D Gil Saladi\u00e9","year":"1992","unstructured":"Gil Saladi\u00e9 D, Delgado Gonz\u00e1lez M . y cols. La depresi\u00f3n de la enfermedad de Parkinson y su relaci\u00f3n con las manifestaciones cognitivas y motoras. Neurolog\u00eda 1992; 7: 176\u2013179.","journal-title":"Neurolog\u00eda"},{"key":"BF6500301_CR14","first-page":"195","volume-title":"Movement Disorders in Neurology and Neuropsychiatry","author":"G Hammond-Tooke","year":"1999","unstructured":"Hammond-Tooke G, Pollock M . Depression, dementia, and Parkinson's disease. In: Hoseph AB, Young RR (eds). Movement Disorders in Neurology and Neuropsychiatry, 2 edn. Blackwell Science: Massachusetts, 1999, pp 195\u2013204."},{"key":"BF6500301_CR15","first-page":"513","volume-title":"Psychopharmacology: The Third Generation of Progress","author":"HY Meltzer","year":"1987","unstructured":"Meltzer HY, Lowy MT . The serotonin hypothesis of depression. In: Meltzer HY (eds). Psychopharmacology: The Third Generation of Progress. Raven Press: New York, 1987, pp 513\u2013526."},{"key":"BF6500301_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","volume":"13","author":"AC Howlett","year":"1990","unstructured":"Howlett AC, Bidaut-Rusell M, Devane WA, Melvin LS, Johnson MR, Herkenham M . The cannabinoid receptor: biochemical, anatomical and behavioural characterization. Trends Neurosci 1990; 13: 420\u2013423.","journal-title":"Trends Neurosci"},{"key":"BF6500301_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","volume":"83","author":"K Tsout","year":"1998","unstructured":"Tsout K, Brown S, Sa\u00f1udo-Pe\u00f1a MC, Mackie K, Walker JM . Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998; 83: 393\u2013411.","journal-title":"Neuroscience"},{"key":"BF6500301_CR18","first-page":"880","volume":"3","author":"MR Hoehe","year":"1991","unstructured":"Hoehe MR, Caenazzo L, Martinez MM, Hsieh WT, Modi WS, Gershon ES et al. Genetic and physical mapping of the human cannabinoid receptor gene chromosome 6q14\u2013q15. New Biol 1991; 3: 880\u2013885.","journal-title":"New Biol"},{"key":"BF6500301_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1042\/bj2790129","volume":"279","author":"CM Gerard","year":"1991","unstructured":"Gerard CM, Mollereau C, Vassart G, Parmentier M . Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 1991; 279: 129\u2013134.","journal-title":"Biochem J"},{"key":"BF6500301_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","volume":"109","author":"H Hermann","year":"2002","unstructured":"Hermann H, Marsicano G, Lutz B . Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 2002; 109: 451\u2013460.","journal-title":"Neuroscience"},{"key":"BF6500301_CR21","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","volume":"57","author":"KA Sieradzan","year":"2001","unstructured":"Sieradzan KA, Fox SH, Hill M, Disck JP, Crossman AR, Brotchie JM et al. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 2001; 57: 2108\u20132111.","journal-title":"Neurology"},{"key":"BF6500301_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0024-3205(99)00293-3","volume":"65","author":"MC Sa\u00f1udo-Pe\u00f1a","year":"1999","unstructured":"Sa\u00f1udo-Pe\u00f1a MC, Tsoy K, Walker JM . Motor action of cannabinoids in the basal ganglia output nuclei. Life Sci 1999; 65: 713.","journal-title":"Life Sci"},{"key":"BF6500301_CR23","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1046\/j.0953-816x.2001.01812.x","volume":"14","author":"I Lastres-Becker","year":"2001","unstructured":"Lastres-Becker I, Cebeira M, de Cevallos M, Zeng B-Y, Jenner P, Ramos JA . Fern\u00e1ndez\u2013Ruiz increased cannabinoid CB1 receptor binding and activation of GPT-binding proteins in the basal ganglia of patients with Parkinson's disease and MPTP-treated marmosets. Eur J Neurosci 2001; 14: 1827\u20131832.","journal-title":"Eur J Neurosci"},{"key":"BF6500301_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0140-6736(82)91270-3","volume":"2","author":"D Rottanburg","year":"1982","unstructured":"Rottanburg D, Robins AH, Ben-Arie O, Teggin A, Elk R . Cannabis associated psychosis with hipomanic features. Lancet 1982; 2: 1364\u20131366.","journal-title":"Lancet"},{"key":"BF6500301_CR25","first-page":"605","volume":"34","author":"AA Devane","year":"1988","unstructured":"Devane AA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC . Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988; 34: 605\u2013613.","journal-title":"Mol Pharmacol"},{"key":"BF6500301_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cne.903270406","volume":"327","author":"LA Matsuda","year":"1993","unstructured":"Matsuda LA, Bonner TI, Lolait SJ . Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 1993; 327: 535\u2013550.","journal-title":"J Comp Neurol"},{"key":"BF6500301_CR27","first-page":"74","volume":"194","author":"SP Banerjee","year":"1975","unstructured":"Banerjee SP, Synder SH, Mechulam R . Cannabinoids: L influence on neurotransmitter uptake in rat brain synaphosomes. J Pharmacol Exp Ther 1975; 194: 74\u201381.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF6500301_CR28","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/0024-3205(95)00202-H","volume":"56","author":"RE Musty","year":"1995","unstructured":"Musty RE, Kaback L . Relationships between motivation and depression in chronic marijuana users. Life Sci 1995; 56: 2151\u20132158.","journal-title":"Life Sci"},{"key":"BF6500301_CR29","unstructured":"Mato S, Rodriguez-Puertas R, Gonz\u00e1lez-Maeso J, Meana J, Sall\u00e9s J, Pazos A . Receptores centrales para cannabinoides en cerebro humano postmortem: estudio radiom\u00e9trico en la depresi\u00f3n mayor. 1a Reuni\u00f3n nacional sobre investigaci\u00f3n en cannabinoides, Madrid, 2000."},{"key":"BF6500301_CR30","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.1073\/pnas.122149199","volume":"99","author":"D Robbe","year":"2002","unstructured":"Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ . Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 2002; 99: 8384\u20138388.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6500301_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-0327(01)00420-7","volume":"72","author":"NWJ Wainwright","year":"2002","unstructured":"Wainwright NWJ, Surtees PG . Childhood adversity, gender and depression over the life-course. J Affect Disorders 2002; 72: 33\u201344.","journal-title":"J Affect Disorders"},{"key":"BF6500301_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","volume":"159","author":"M Martin","year":"2002","unstructured":"Martin M, Ledent C, Parmentir M, Maldonado R, Valverde O . Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 2002; 159: 379\u2013387.","journal-title":"Psychopharmacology"},{"key":"BF6500301_CR33","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/00041444-199524000-00005","volume":"5","author":"E Dawson","year":"1995","unstructured":"Dawson E . Identification of a polymorphic triplet repeat marker for the brain cannabinoid receptor gene: use in linkage and association studies. Psychiat Genet 1995; 5: S50.","journal-title":"Psychiat Genet"},{"key":"BF6500301_CR34","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045\u20132047.","journal-title":"Science"},{"key":"BF6500301_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00019052-200108000-00008","volume":"14","author":"Y Mizuno","year":"2001","unstructured":"Mizuno Y, Hattori N, Mori H, Suzuki T, Tanaka K . Parkin and Parkinson's disease. Curr Opin Neurol 2001; 14: 477\u2013482.","journal-title":"Curr Opin Neurol"},{"key":"BF6500301_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1469-1809.2001.6520111.x","volume":"65","author":"JR Vaughan","year":"2001","unstructured":"Vaughan JR, Davis MB, Wood NW . Genetics of Parkinsonism: a review. Ann Hum Genet 2001; 65: 111\u2013126.","journal-title":"Ann Hum Genet"},{"key":"BF6500301_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1212\/WNL.55.4.533","volume":"55","author":"EK Tan","year":"2000","unstructured":"Tan EK, Khajavi M, Thornby JL, Nagamitsu S, Jankovic J, Ashizawa T . Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000; 55: 533\u2013538.","journal-title":"Neurology"},{"key":"BF6500301_CR38","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1016\/S0021-9258(19)49776-7","volume":"267","author":"GP Schroth","year":"1992","unstructured":"Schroth GP, Chou PJ, Ho PS . Mapping Z-DNA in the human genome. Computer-aided mapping reveals a nonrandom distribution of potential Z-DNA-forming sequences in human genes. J Biol Chem 1992; 267: 11846\u201311855.","journal-title":"J Biol Chem"},{"key":"BF6500301_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00041444-199623000-00064","volume":"6","author":"DE Comings","year":"1996","unstructured":"Comings DE . Polygenic inheritance and minisatellites. Psychiat Genet 1996; 6: 157\u2013158.","journal-title":"Psychiat Genet"},{"key":"BF6500301_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ajmg.1259","volume":"105","author":"SJ Tsai","year":"2001","unstructured":"Tsai SJ, Wang YC, Hong CJ . Association study between cannabonoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders. Am J Med Genet 2001; 105: 219\u2013221.","journal-title":"Am J Med Genet"},{"key":"BF6500301_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.mp.4000247","volume":"2","author":"DE Comings","year":"1997","unstructured":"Comings DE, Muhleman D, Gade R, Jonson P, Verde R, Saucier G et al. Cannabinoid receptor gene (CNR1): association with IV drug abuse. Mol Psychiatry 1997; 2: 161\u2013168.","journal-title":"Mol Psychiatry"},{"key":"BF6500301_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0376-8716(01)00164-8","volume":"65","author":"G Lutz","year":"2002","unstructured":"Lutz G, Schmidt T, Samochowiec J, Finckh U, Fiser-Piosik E, Horodinicki J et al. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depen 2002; 65: 221\u2013224.","journal-title":"Drug Alcohol Depen"},{"key":"BF6500301_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.mp.4001029","volume":"7","author":"H Ujike","year":"2002","unstructured":"Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 2002; 7: 515\u2013518.","journal-title":"Mol Psychiatry"},{"key":"BF6500301_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13556210020040271","volume":"6","author":"D Heller","year":"2001","unstructured":"Heller D, Schneider U, Seifert J, Cimander KF, Stuhrmann M . The cannabinoid receptor gene (CNR1) is not affected in German i.v. drugs users. Addict Biol 2001; 6: 183\u2013187.","journal-title":"Addict Biol"},{"key":"BF6500301_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.mp.4000670","volume":"5","author":"T Li","year":"2000","unstructured":"Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM et al. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 2000; 5: 128\u2013130.","journal-title":"Mol Psychiatry"},{"key":"BF6500301_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.mp.4001376","volume":"9","author":"BL Hungund","year":"2004","unstructured":"Hungund BL, Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, Cooper TB et al. Upregulation of CB1 receptors and agonist-stimulated [35S] GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 2004; 9: 184\u2013190.","journal-title":"Mol Psychiatry"},{"key":"BF6500301_CR47","first-page":"257","volume-title":"Movement Disorders. Neurologic Principles and Practice","author":"E Melamed","year":"1997","unstructured":"Melamed E . Neurobehavioral abnormalities in Parkinson's disease. In: Watt RL, Koller WC (eds). Movement Disorders. Neurologic Principles and Practice. McGraw-Hill: New York, 1997, pp 257\u2013261."},{"key":"BF6500301_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33588\/rn.27155.98056","volume":"27","author":"JM Errea-Abad","year":"1998","unstructured":"Errea-Abad JM, Ara-Callizo JR, Aibar-Rem\u00f3n C . Drug-induced Parkinsonism. Clinical aspects compared with Parkinson disease. Rev Neurol 1998; 27: 35\u201339.","journal-title":"Rev Neurol"},{"key":"BF6500301_CR49","first-page":"49","volume":"65","author":"HS Mayberg","year":"1995","unstructured":"Mayberg HS, Solomon DH . Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol 1995; 65: 49\u201360.","journal-title":"Adv Neurol"},{"key":"BF6500301_CR50","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1176\/ajp.151.7.1010","volume":"151","author":"P Hantz","year":"1994","unstructured":"Hantz P, Caradoc-Davis G, Caradoc-Davis T, Weatherall M, Dixon G . Depression in Parkinson's disease. Am J Psychiatry 1994; 151: 1010\u20131014.","journal-title":"Am J Psychiatry"},{"key":"BF6500301_CR51","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1212\/WNL.36.8.1130","volume":"36","author":"J Santamar\u00eda","year":"1986","unstructured":"Santamar\u00eda J, Tolosa E, Valles A . A Parkinson's disease with depression: a possible subgroup of idiopathic Parkinsonism. Neurology 1986; 36: 1130\u20131133.","journal-title":"Neurology"},{"key":"BF6500301_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/mds.870130109","volume":"13","author":"SE Starkstein","year":"1998","unstructured":"Starkstein SE, Petracca G, Chemerinski E, Teson A, Sabe L, Merello M et al. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord 1998; 13: 29\u201333.","journal-title":"Mov Disord"},{"key":"BF6500301_CR53","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.31.6.645","volume":"31","author":"R Mayeux","year":"1991","unstructured":"Mayeux R, Stern Y, Rosen J, Leventhal J . Depression, intellectual impairment and Parkinson's disease. Neurology 1991; 31: 645\u2013650.","journal-title":"Neurology"},{"key":"BF6500301_CR54","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/sj.mp.4001278","volume":"8","author":"G Ponce","year":"2003","unstructured":"Ponce G, Hoenicka J, Rubio G, Ampuero I, Jim\u00e9nez-Arriero MA, Rodr\u00edguez-Jimenez R et al. Association between the cannabinoid receptor gene (CNR1) and childhood attention-deficit\/hyperactivity disorder in Spanish male alcoholic, patients. Mol Psychiatry 2003; 8: 466\u2013467.","journal-title":"Mol Psychiatry"},{"key":"BF6500301_CR55","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1517\/14728222.5.5.601","volume":"5","author":"KA Macritchie","year":"2001","unstructured":"Macritchie KA, Young AH . Emerging targets for the treatment of depressive disorder. Expert Opin Ther targets 2001; 5: 601\u2013612.","journal-title":"Expert Opin Ther targets"},{"key":"BF6500301_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gliman S . Diagnostic criteria for Parkinson Disease. Arch Neurol 1999; 56: 33\u201339.","journal-title":"Arch Neurol"},{"key":"BF6500301_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD . Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427\u2013442.","journal-title":"Neurology"},{"key":"BF6500301_CR58","first-page":"153","volume-title":"Recent Developments in Parkinson's Disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL . Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds). Recent Developments in Parkinson's Disease, vol. 2. Macmillan Healthcare information: Florham Park, NJ, 1987, pp 153\u2013163, 293\u2013304."},{"key":"BF6500301_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/6500301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6500301","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6500301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T20:15:33Z","timestamp":1734898533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6500301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,25]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4,1]]}},"alternative-id":["BF6500301"],"URL":"https:\/\/doi.org\/10.1038\/sj.tpj.6500301","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,25]]},"assertion":[{"value":"29 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}